NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)
NT trends in ecstasy and related drug markets; Reports; PublicationNT
Made available via the Publications (Legal Deposit) Act 2004 (NT).
Date:2011; Australian drug trends series No. 80
Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals
National Drug and Alcohol Research Centre, University of New South Wales
Check within Publication or with content Publisher.
xv past six months (5%), median days used (6 days) and median days injected (8 days) largely mirrored the 2010 results. The median price for 8mg of Subutex was $23, the same median price as reported in 2010. Only seven participants commented upon current availability, with five participants rating current availability as difficult, one rating it as easy and one rating current availability as very difficult. Suboxone Fourteen percent of the sample had recently used illicit Suboxone (15% in 2010) on a median of 2 days. Three percent of the sample had recently injected illicit Suboxone, on a median of 2 days. Two participants reported purchasing illicit 8mg Suboxone (one for $30 and the other for $70) and no participants reported purchasing 2mg Suboxone. In 2010, the median price for 8mg Suboxone was $20. Three of the five participants who commented upon current availability rated it as difficult while the other two respondents rated current availability as very difficult. Over-the-counter codeine Fifty-two percent of the sample reported recent use of over-thecounter (OTC) codeine in the previous six months, a notably higher proportion than the 35% who reported recent OTC codeine use in 2010 and 2009. As in 2010, only one respondent reported injecting OTC codeine although median days injected increased from 10 days in 2010 to 72 days in 2011. Nurofen Plus was again the most commonly used OTC brand of codeine. Benzodiazepines Sixty-one percent of the sample had recently used any form of benzodiazepines, an increase from the 52% who reported recent use in 2010. Recent injection of benzodiazepines remained stable, at about one-fifth of the sample. Median days used increased to 37 days from 33 days in 2010. As in 2010, licit benzodiazepines were the form recently used by most respondents (30% of the sample). In 2011, Alprazolam was investigated separately and results showed that 36% of respondents reported recent use of illicit Alprazolam whereas 13% reported recent use of licit Alprazolam. Twenty percent of the sample reported recent injection of illicit Alprazolam while only 3% reported recent injection of licit Alprazolam. Ecstasy, LSD, Seroquel, inhalants, tobacco and alcohol Recent ecstasy use continued to decline in 2011, with 9% reporting use within the past six months (10% in 2010 and 20% in 2009) and no respondents reporting injection of the substance (4% in 2010 and 10% in 2009). Weekly or less was the only pattern of ecstasy use reported. Recent use of hallucinogens by participants remained low at 7% of the sample, but this still represented an increase from the 4% who reported recent use in 2010. As in the past two years, no respondents reported injection of the drug and median days of use remained low at 3 days. Two respondents reported recent use illicit Seroquel and three reported recent use of licit Seroquel. In 2011, no participants reported recent inhalant use (one in 2010). Ninety-seven percent of the sample reported daily use of tobacco (90% in 2010). Sixty-three percent of the sample reported recent alcohol use (57% in 2010), with weekly or less the main pattern of use reported. Health Two participants had overdosed on heroin in the past 12 months. Eight participants had overdosed on a drug other than heroin in the past year: four from benzodiazepines, two from morphine and two from other opiates.